TherapeuticsMD
TXMD
TXMD
168 hedge funds and large institutions have $467M invested in TherapeuticsMD in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
+18
Holders Change %
+12%
% of All Funds
3.32%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
57
Reduced
39
Closed
13
Calls
$3.33M
Puts
$2.4M
Net Calls
+$932K
Net Calls Change
+$1.75M
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$10M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.52M |
| 3 |
DM
Deerfield Management
New York
|
+$5.45M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.78M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$4.45M |
